The Milken Institute Future of Health Summit convenes the best minds in the world to confront the toughest challenges in health by matching human, financial, and scientific resources with the most innovative, inclusive, and impactful ideas to drive better health outcomes for all.
TransCelerate CEO Janice Chang will join a summit panel alongside TransCelerate board member Rob Metcalf (Eli Lilly and Company), Amy Abernethy (Highlander Health), Owen Garrick, MD (Mayo Clinic), and Ann Meeker-O’Connell (US FDA), moderated by Mark McClellan (Duke-Margolis Institute for Health Policy). The nature of drug development is changing; precision medicine as one example. How can clinical trials adapt? The panel will discuss the range of pilots in place to deliver much-needed innovations to trial design, regulation, and conduct.